France changed the funding of certain weight-management medicines in 2026. Older advice saying that all weight-loss injections must always be self-funded is no longer sufficient. Equally, the new arrangements do not mean that every prescription will automatically be reimbursed.
What changed in June 2026
France’s Assurance Maladie confirms possible coverage for certain adults with obesity. The arrangements concern Wegovy and Mounjaro under defined conditions. A prescription or the product’s marketing authorisation does not, by itself, establish entitlement.
Check dates when comparing prices or personal accounts online. An article from 2025 may have been accurate at the time while no longer describing your current situation. Ask specifically about the rules for the indication and formulation being prescribed.
Have all clinical requirements assessed
According to ameli, relevant groups include adults with an initial BMI of at least 40, or at least 35 with a specified weight-related condition. There must also have been insufficient benefit from six months of appropriately conducted nutritional care. This outline does not replace assessment of the complete requirements.
Not every condition accompanying higher weight automatically qualifies. Ask the team which findings matter and which previous care needs to be documented. These thresholds are not a self-diagnosis tool and should never be a reason to accept weight gain in order to cross a boundary.
Who can issue the reimbursable initial prescription
Starting treatment through the reimbursement pathway requires an eligible prescriber with the specified involvement in specialist obesity care. An initial prescription from any medical practice is therefore different from the first prescription required for this funding route.
General practitioners and other doctors can be involved in follow-up prescriptions. When booking, ask whether the practice can provide the appropriate route or refer you to an eligible service. That can prevent paying for a consultation based on a mistaken expectation about coverage.
The supporting form is part of the process
The correctly completed supporting form matters alongside the prescription. It records the required assessment and must be presented when the medicine is dispensed. People who were already taking Wegovy or Mounjaro for obesity before 15 June 2026 also need the specified documentation to use the new coverage arrangements.
Keep the form with your prescriptions. Before obtaining a supply, ask the pharmacy whether the necessary documents are complete. Missing information should be resolved with the practice; reimbursement after a private purchase should not simply be assumed.
Compare actual costs and lawful supply
Request a clear breakdown: Which amount concerns the medicine, which concerns medical care, and which covers additional support? Also clarify what you personally will pay under your insurance arrangements. A general announcement about reimbursement is not an individual promise of payment.
The French register of authorised online pharmacies concerns medicines that do not require a mandatory prescription. It does not establish a lawful online purchase route for prescription GLP-1 medicines. Ask a pharmacy to check regular supply. EU authorisation of new tablets likewise does not automatically establish a French launch or coverage.
Common questions
I started treatment before June 2026. Am I automatically covered?
No. According to ameli, people already receiving treatment also need the required form completed by an eligible prescriber. Clinical and procedural conditions still need assessment. Have your existing documents reviewed rather than treating a previously private prescription as automatically funded.
Does this also describe Mounjaro prescribed for diabetes?
Coverage of type 2 diabetes treatment has its own conditions. This article describes the obesity pathway. Tell the practice and pharmacy exactly which purpose appears on the prescription so that the relevant rules, rather than assumptions based on the product name, can be checked.
Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact